Search research articles
Contact Us
Filters
Showing results (161-170 of 204) with videos related to
Page
of 21
Sort By:
Contraception
|
September 7, 2019
Feasibility of a hospital outpatient day procedure for medication abortion at 13-18 weeks gestation: Findings from Nepal<sup>.</sup>
Jennifer Blum, Chanda Karki, Anand Tamang, et al.
Obstetrics and Gynecology
|
March 5, 2016
Vaginal and Rectal Clostridium sordellii and Clostridium perfringens Presence Among Women in the United States
Erica Chong, Beverly Winikoff, Dyanna Charles, et al.
Contraception
|
November 22, 2023
Evaluation of a "smart" screening tool for asynchronous assessment of medication abortion eligibility: A pilot study
Elizabeth G Raymond, Laura J Frye, Kristina Tocce, et al.
BMC Pregnancy and Childbirth
|
September 16, 2015
The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in rural Uganda: a community-based, placebo-controlled randomised trial
Andrew D Weeks, James Ditai, Sam Ononge, et al.
Contraception
|
April 13, 2016
Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone
Jennifer Blum, Wendy R Sheldon, Nguyen Thi Nhu Ngoc, et al.
Obstetrics and Gynecology
|
August 24, 2011
Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial
Nguyen Thi Nhu Ngoc, Tara Shochet, Sheila Raghavan, et al.
Contraception
|
July 30, 2021
Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S
Holly A Anger, Elizabeth G Raymond, Melissa Grant, et al.
BMC Pregnancy and Childbirth
|
November 16, 2012
Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries
Tara Shochet, Ayisha Diop, Alioune Gaye, et al.
Contraception
|
December 17, 2013
A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial
Hillary Bracken, Rasha Dabash, George Tsertsvadze, et al.
Obstetrics and Gynecology
|
October 24, 2012
Extending outpatient medical abortion services through 70 days of gestational age
Beverly Winikoff, Ilana G Dzuba, Erica Chong, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 204) with videos related to
Sort By:
Page
of 21
Contraception
|
September 7, 2019
Feasibility of a hospital outpatient day procedure for medication abortion at 13-18 weeks gestation: Findings from Nepal<sup>.</sup>
Jennifer Blum, Chanda Karki, Anand Tamang, et al.
Obstetrics and Gynecology
|
March 5, 2016
Vaginal and Rectal Clostridium sordellii and Clostridium perfringens Presence Among Women in the United States
Erica Chong, Beverly Winikoff, Dyanna Charles, et al.
Contraception
|
November 22, 2023
Evaluation of a "smart" screening tool for asynchronous assessment of medication abortion eligibility: A pilot study
Elizabeth G Raymond, Laura J Frye, Kristina Tocce, et al.
BMC Pregnancy and Childbirth
|
September 16, 2015
The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in rural Uganda: a community-based, placebo-controlled randomised trial
Andrew D Weeks, James Ditai, Sam Ononge, et al.
Contraception
|
April 13, 2016
Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone
Jennifer Blum, Wendy R Sheldon, Nguyen Thi Nhu Ngoc, et al.
Obstetrics and Gynecology
|
August 24, 2011
Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial
Nguyen Thi Nhu Ngoc, Tara Shochet, Sheila Raghavan, et al.
Contraception
|
July 30, 2021
Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S
Holly A Anger, Elizabeth G Raymond, Melissa Grant, et al.
BMC Pregnancy and Childbirth
|
November 16, 2012
Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries
Tara Shochet, Ayisha Diop, Alioune Gaye, et al.
Contraception
|
December 17, 2013
A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial
Hillary Bracken, Rasha Dabash, George Tsertsvadze, et al.
Obstetrics and Gynecology
|
October 24, 2012
Extending outpatient medical abortion services through 70 days of gestational age
Beverly Winikoff, Ilana G Dzuba, Erica Chong, et al.
Page
of 21